Medtronic's stock has lost around a third of its value since late 2022. However, stock prices for longtime dividend growers ...

Medtronic (NYSE:MDT) shares snapped seven straight days of losses as the stock closed 0.85% higher, at $88.98 on Thursday. ...

Medtronic’s top ventilator executive began fielding pleas from world leaders' representatives five years ago, as pressure ...

Medtronic (MDT) closed the latest trading day at $88.98, indicating a +0.85% change from the previous session's end. The stock outperformed the S&P 500, which registered a daily loss of 0.33%.

The U.S. Food and Drug Administration on Tuesday classified the recall of Medtronic's embolization device as "most serious", ...

In a report released yesterday, Lee Hambright from Bernstein maintained a Buy rating on Medtronic (MDT – Research Report), with a price target ...

Medtronic’s diverse portfolio faces financial growth concerns. Learn why MDT stock is a HOLD, offering stability but limited growth in the short term.

Shares of Medtronic PLC MDT shed 1.71% to $88.59 Tuesday, on what proved to be an all-around positive trading session for the ...

Evolut showed less bioprosthetic valve dysfunction, prosthetic valve thrombosis and haemodynamic structural valve dysfunction ...

Medtronic reported 4.1% organic revenue growth and 6.2% adjusted EPS growth. See why we upgraded MDT stock to 'Buy' with a ...

Medtronic has recalled certain Pipeline Vantage Embolization Devices with Shield Technology due to an increased risk of ...

Medtronic will remove one model of Pipeline Vantage devices from where they’re used and sold and will update the instructions ...